title: 17 years of clinical experience with phosphodiesterase type 5 inhibitors: what do we have yet to learn?
authors.affiliation: Department of Urology, University of Naples Federico II, Naples, Italy. Electronic address: pverze@gmail.com.
authors.forename: Paolo
authors.initials: P
authors.lastname: Verze
authors.affiliation: Urology Unit, Santa Chiara Hospital, Trento, Italy.
authors.forename: Tommaso
authors.initials: T
authors.lastname: Cai
authors.affiliation: Department of Urology, University of Naples Federico II, Naples, Italy.
authors.forename: Alessandro
authors.initials: A
authors.lastname: Palmieri
authors.affiliation: Department of Urology, University of Naples Federico II, Naples, Italy.
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Mirone
mesh_terms: D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010410:Penile Erection / Q000187:drug effects*; D058986:Phosphodiesterase 5 Inhibitors / Q000008:administration & dosage*
chemical_list: D058986:Phosphodiesterase 5 Inhibitors